SOHO 2023 Eleventh Annual Meeting
S

SOHO 2023: Addressing Anemia in Myelofibrosis

By SOHO 2023 Eleventh Annual Meeting FEATURING Stephen Oh
By SOHO 2023 Eleventh Annual Meeting FEATURING Stephen Oh
0 views
October 18, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Recommended

AUTOPLAY
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
21:20
Cleveland Clinic Rheumatology

How do I Recognize and Treat the VEXAS Syndrome?

Feat. P. Grayson
26:22
Agios

Pyruvate Kinase Deficiency: An Underrecognized Cause of Chronic Hemo…

Feat. J. M. Despotovic
19:28
Agios

Pyruvate Kinase Deficiency: Clinical Manifestations and Treatment Ap…

Feat. K. Yotsumoto Fertrin
24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi
30:41
Icahn School of Medicine at Mount Sinai

How to Approach Anemia

Feat. C. Cromwell
61:16
Scripps Health

Anemia: Beyond Iron Deficiency!

Feat. A. Goodman
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
27:37
Indy Hematology Review

Review of Myeloproliferative Neoplasms

Feat. A. Tefferi
18:04
Ruben Mesa

Momelotinib for Myelofibrosis: Top 10 Things You Should Know Post-FD…

33:17
Indy Hematology Review

Managing Benign Hematology Disorders

Feat. C. Kessler
06:18
Cleveland Clinic Taussig Cancer Institute

SIMPLIFY-2 Trial: Momelotinib Vs. Continued Ruxolitinib or Best Avai…

Feat. A. Gerds
10:02
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of MPNs - Highlights & Key Take…

Feat. R. Mesa
21:52
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Imp…

Feat. D. Tremblay
15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
11:39
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

2024 Updates in Myeloproliferative Neoplasms

Feat. E. Hexner
31:43
Indy Hematology Review

Myelofibrosis: Chronic and Blast Phase - 2023 Algorithms for Risk St…

Feat. A. Tefferi
20:28
Srikanth Nagalla

Approach to Hemolytic Anemia

18:42
Memorial Sloan Kettering Cancer Center

Key Updates in AML, MDS, & MF From ASH

Feat. A. Goldberg
24:48
Indy Hematology Review

2024 Updates on Myelofibrosis and Systemic Mastocytosis

Feat. R. Rampal